Innovator, researcher and people leader with an extensive experience in molecular biology, protein production optimization, organism genetic engineering, synthetic biology, AI/ML and many other areas of biological science.MAIN AREAS OF EXPERTISE:• Biotech, Pharma, Foodtech, Cleantech• Molecular & Microbiology• Strain, Protein & Metabolic engineering• AI & Machine Learning• BD, Operations & External communication • Strain & DNA banking systems• Microbiome & Oncobiotics• Structural & Synthetic biology• Immunology• Team, Project & Alliance managementHIGHLIGHTS AND ACHIEVEMENTS:• Initiated and led design and implementation of project information and strain/DNA storage systems for Conagen and Ginkgo. Designed and was leading the biggest (at the time) Ginkgo project, that resulted in launching first cultured cannabinoid product: THC & CBG infused gummy – Speenach Feelz®. During pandemic, was leading technical team developing pooled COVID test for schools resulting in launching commercial product Concentric by Ginkgo. Developed first GMO yeast strain approved in U.S. by AAFCO regulatory agency for use in corn ethanol industry, launching Mascoma’s first commercial product - TransFerm®. Built from scratch molecular biology labs and teams for Evelo and Total.• Inventor on multiple issued patents and patent applications for metabolic engineering to produce pharmaceuticals, biochemicals and biofuels (Ginkgo, Total, Mascoma), methods for protein expression optimization, methods to improve yeast strains for human antibodies production (Merck), providing online research services, and many others.• Finalist, 2003 Cournand and Comroe Young Investigator Prize (American Heart Association), for paper on mechanisms of apoptosis in pulmonary vascular smooth muscle cells. Two papers in Science including the paper on hexameric structure of the human interleukin-6/IL-6 alpha-receptor/gp130 complex, and more than 20 other peer-reviewed journal publications.